News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
146 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (18848)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3141)
September (3205)
October (3539)
November (3386)
December (2332)
Day
1 (103)
2 (1)
4 (140)
5 (169)
6 (148)
7 (144)
8 (68)
9 (22)
10 (23)
11 (209)
12 (180)
13 (124)
14 (146)
15 (82)
17 (2)
18 (146)
19 (143)
20 (110)
21 (123)
22 (70)
24 (1)
25 (2)
26 (8)
27 (78)
28 (44)
29 (45)
30 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
22
24
25
26
27
28
29
30
Biotech Beach
Puma Biotechnology Added to NASDAQ Biotechnology Index
Puma will be added to the NBI effective prior to market open on Monday, December 18, 2017.
December 14, 2017
·
3 min read
Biotech Beach
San Diego’s AmpliPhi Biosciences Is Reviewing Strategic Alternatives
AmpliPhi Biosciences announced its progress in 2017 and near-term strategic goals and initiatives.
December 14, 2017
·
7 min read
Business
Gilead Sciences Announces That John C. Martin, PhD Will Transition From Executive Chairman to Chairman of the Board of Directors
Gilead Sciences announced that Executive Chairman John Martin, PhD will transition from his current role of Executive Chairman to Chairman of the Board of Directors effective March 9, 2018.
December 14, 2017
·
1 min read
Pharm Country
AmerisourceBergen Foundation Launches Municipal Support Program to Help Combat Opioid Abuse
The AmerisourceBergen Foundation today announced the launch of a municipal support program that aims to promote the safe disposal of opioids by providing communities nationwide with resources to deactivate expired or unused prescription medications.
December 14, 2017
·
3 min read
Management Shakeup at Cash-Strapped Presbia, New Leader Named
The company also received an investment proposal from Orchard Capital Corporation to invest up to $5 million in the Company’s preferred shares.
December 14, 2017
·
4 min read
Policy
CanniMed Therapeutics Receives Municipal Approval from Carp Lake Township to Apply for State of Michigan Licenses for Medical Cannabis Production and Processing
The Company intends to submit an application for a Class C Grower License as well as a Processor License to the State of Michigan on or about the opening of the application period, December 15, 2017.
December 14, 2017
·
5 min read
Genetown
Verastem Announces Public Offering of Common Stock
Verastem announced that it intends to offer and sell $25 million of its common stock in an underwritten public offering.
December 14, 2017
·
3 min read
ICC International Cannabis Corporation Changes its Name to ICC Labs Inc. to Reflect Medicinal and Pharmaceutical Opportunity
The Company is expected to commence trading under its new name at the opening of trading on the day after it receives final approval from the TSX Venture Exchange.
December 14, 2017
·
5 min read
FDA
Pfizer Announces FDA Approval of XELJANZ (tofacitinib) and XELJANZ XR for the Treatment of Active Psoriatic Arthritis
The approval was based on data from the Phase 3 Oral Psoriatic Arthritis Trial (OPAL) clinical development program.
December 14, 2017
·
18 min read
Business
Little reMYND Forges 350M+ Euros Tie-Up With Drug Giant Novo Nordisk
reMYND’s pre-clinical diabetes therapy ReS39 will get a significant boost after the company entered a licensing agreement with noted European diabetes company Novo Nordisk.
December 14, 2017
·
2 min read
·
Alex Keown
Previous
13 of 15
Next